Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
ClinicalTrials.gov study NCT05320198. IPD Sharing: NO. Countries: 1. Publications: 0.
A Retrospective Study to Describe Real-World Treatment Patterns and Clinical Outcomes Among Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT06581055. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study of Venetoclax Combined With Azacitidine as Bridging Therapy Prior to Hematopoietic Stem Cell Transplantation in Patients With Higher-Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT07047183. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Trial of Omacetaxine, Azacitidine, and Growth-Colony Stimulating Factor (G-CSF) for Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT02835794. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Intensified Azacitidine in High Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01305460. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00624936. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT01196715. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants
ClinicalTrials.gov study NCT06045689. IPD Sharing: Not stated. Countries: 9. Publications: 0.
Nivolumab and Ipilimumab After Donor Stem Cell Transplant in Treating Patients With High Risk Refractory or Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03600155. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Amifostine in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00003048. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in Japan
ClinicalTrials.gov study NCT06298643. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT03886662. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Therapy of SyB C-1101 and Azacytidine in Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02783547. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia
ClinicalTrials.gov study NCT05883956. IPD Sharing: NO. Countries: 2. Publications: 0.
Study of SGR-2921 in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT05961839. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Cusatuzumab Plus Azacitidine in Japanese Participants With Newly Diagnosed Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome Who Are Not Candidates for Intensive Treatment
ClinicalTrials.gov study NCT04241549. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00234000. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01314599. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Erlotinib in Higher Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01085838. IPD Sharing: NO. Countries: 1. Publications: 0.
VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00049686. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.